# EDGAR Filing Document

**Accession Number:** 0001777095
**File Stem:** 0001777095-25-000003
**Filing Date:** 2025-11
**Character Count:** 8155
**Document Hash:** 7b95b2429e9c05a85451b26ca83d51dd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001777095-25-000003.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 0001777095-25-000003

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251115

**FILED AS OF DATE**: 20251117

**DATE AS OF CHANGE**: 20251117

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Talvitie Kristian
- **CENTRAL INDEX KEY:** 0001777095

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-18059
- **FILM NUMBER:** 251491980

**MAIL ADDRESS:**
- **STREET 1:** 121 SEAPORT BOULEVARD
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PTC INC.
- **CENTRAL INDEX KEY:** 0000857005
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 042866152
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 121 SEAPORT BOULEVARD
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 7813705000

**MAIL ADDRESS:**
- **STREET 1:** 121 SEAPORT BOULEVARD
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PARAMETRIC TECHNOLOGY CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Talvitie Kristian<br><sub>(Last) (First) (Middle)</sub><br>121 SEAPORT BOULEVARD<br><sub>(Street)</sub><br>BOSTON, MA 02210<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP, Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PTC INC. [ PTC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-11-15 |  | M |  | 32140 | A | $0 | 79557<sup>(1)</sup> | D |  |
| Common Stock | 2025-11-15 |  | F |  | 14574<sup>(2)</sup> | D | $179.61 | 64983 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 2079 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 2079 | $0 | 0<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 11090 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 11090 | $0 | 0<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 5134 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 5134 | $0 | 0<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 2182 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 2182 | $0 | 2693<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 5387 | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 5387 | $0 | 5387<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 1960 | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 1960 | $0 | 4307<sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-11-15 |  | M |  |  | 4308 | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 4308 | $0 | 8614<sup>(10)</sup> | D |  |

---

### Footnotes:

(1) Amount reflects 71 shares purchased under the 2016 Employee Stock Purchase Plan for the offering period ending January 31, 2025 and 64 shares purchased under the 2016 Employee Stock Purchase Plan for the offering period ending July 31, 2025.

(2) Tendered to Issuer to satisfy tax withholding obligations of the Reporting Person incurred in connection with the vesting of the Reporting Person's restricted stock unit awards.

(3) Each restricted stock unit represents a contingent right to receive one share of PTC Inc. common stock.

(4) Performance-based RSUs granted on November 16, 2022 that could be earned for FY25 that were earned and vested on November 15, 2025.

(5) RSUs granted on November 16, 2022 that vested on November 15, 2025.

(6) Performance-based RSUs granted on November 15, 2023 that vest to the extent earned on November 15, 2024, 2025 and 2026.

(7) RSUs granted on November 15, 2023 that vest in three substantially equal installments on November 15, 2024, 2025 and 2026.

(8) Performance-based RSUs granted on November 13, 2024 that vest to the extent earned on November 15, 2025, 2026 and 2027.

(9) RSUs granted on November 13, 2024 that vest in three substantially equal installments on November 15, 2025, 2026 and 2027.

(10) This amount represents the total number of derivative securities beneficially owned of the class shown.

**Signature:** /s/Sean McGrath by power of attorney filed 06/06/2023  
**Date:** 2025-11-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**